Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

The optimal dose of recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke (AIS) remains controversial, especially in Asian countries. We aimed to update the evidence regarding the use of low-dose versus standard-dose rtPA. We performed a systematic literature search across MEDLI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stroke Vasc Neurol
Autores principales: Wang, Xia, You, Shoujiang, Sato, Shoichiro, Yang, Jie, Carcel, Cheryl, Zheng, Danni, Yoshimura, Sohei, Anderson, Craig S, Sandset, Else Charlotte, Robinson, Thompson, Chalmers, John, Sharma, Vijay K
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870642/
https://ncbi.nlm.nih.gov/pubmed/29600005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000112
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares